Advia 1650 Glucose Hexokinase 11 Assay
Hexokinase, Glucose. 510(k) K011963, from Bayer Corp. (Tarrytown, NY). Product code CFR, class 2.
As of Nov 20, 2026, K011963 is an FDA 510(k) held by Bayer Corp., substantially equivalent on Nov 20, 2001 after 151 days, with no recalls tied to it in FDA's recall database.
- Review time: 151 days
- Recalls: 0
The Glucose Hexokinase II in vitro diagnostic procedure is intended to measure glucose in human serum, plasma and urine on the Bayer Advia 1650 system. Such measurement is used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia and insulin overdose.
- Additional Assays for The Bayer Advia 1650 Chemistry SystemK991576 · Bayer Corp. · Jun 30, 1999
- Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsK253490 · Roche Diagnostics · Feb 12, 2026
- Glucose2K252357 · Abbott Ireland · Oct 24, 2025
- cobas pure integrated solutions, Glucose HK Gen.3, ISE indirect Na for Gen.2, ONLINE DAT Methadone II, Elecsys TSHK220134 · Roche Diagnostics · Sep 16, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 22, 2001
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files